FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3000387463> ?p ?o ?g. }

• W3000387463 endingPage "9" @default.
• W3000387463 startingPage "1" @default.
• W3000387463 abstract "Metastatic tumors are the main cause of cancer-related death, as the invading cancer cells disrupt normal functions of distant organs and are nearly impossible to eradicate by traditional cancer therapeutics. This is of special concern when the cancer has created multiple metastases and extensive surgery would be too dangerous to execute. Therefore, combination chemotherapy is often the selected treatment form. However, drug cocktails often have severe adverse effects on healthy cells, whereby the development of targeted drug delivery could minimize side-effects of drugs and increase the efficacy of the combination therapy. In this study, we utilized the folate antagonist methotrexate (MTX) as targeting ligand conjugated onto mesoporous silica nanoparticles (MSNs) for selective eradication of folate receptor-expressing invasive thyroid cancer cells. The MSNs was subsequently loaded with the drug fingolimod (FTY720), which has previously been shown to efficiently inhibit proliferation and invasion of aggressive thyroid cancer cells. To assess the efficiency of our carrier system, comprehensive in vitro methods were employed; including flow cytometry, confocal microscopy, viability assays, invasion assay, and label-free imaging techniques. The in vitro results show that MTX-conjugated and FTY720-loaded MSNs potently attenuated both the proliferation and invasion of the cancerous thyroid cells while keeping the off-target effects in normal thyroid cells reasonably low. For a more physiologically relevant in vivo approach we utilized the chick chorioallantoic membrane (CAM) assay, showing decreased invasive behavior of the thyroid derived xenografts and an increased necrotic phenotype compared to tumors that received the free drug cocktail. Thus, the developed multidrug-loaded MSNs effectively induced apoptosis and immobilization of invasive thyroid cancer cells, and could potentially be used as a carrier system for targeted drug delivery for the treatment of diverse forms of aggressive cancers that expresses folate receptors." @default.
• W3000387463 created "2020-01-23" @default.
• W3000387463 creator A5002498340 @default.
• W3000387463 creator A5007296827 @default.
• W3000387463 creator A5023893071 @default.
• W3000387463 creator A5030780763 @default.
• W3000387463 creator A5035567894 @default.
• W3000387463 creator A5047430062 @default.
• W3000387463 creator A5052741873 @default.
• W3000387463 creator A5056724479 @default.
• W3000387463 creator A5063502488 @default.
• W3000387463 creator A5090795535 @default.
• W3000387463 creator A5091897932 @default.
• W3000387463 date "2020-03-01" @default.
• W3000387463 modified "2023-10-14" @default.
• W3000387463 title "Nanoparticles carrying fingolimod and methotrexate enables targeted induction of apoptosis and immobilization of invasive thyroid cancer" @default.
• W3000387463 cites W141170840 @default.
• W3000387463 cites W1511590410 @default.
• W3000387463 cites W1839954256 @default.
• W3000387463 cites W1842994045 @default.
• W3000387463 cites W1966313764 @default.
• W3000387463 cites W1971560005 @default.
• W3000387463 cites W1972811585 @default.
• W3000387463 cites W1976881265 @default.
• W3000387463 cites W1978917201 @default.
• W3000387463 cites W1979129905 @default.
• W3000387463 cites W1980524534 @default.
• W3000387463 cites W1985801265 @default.
• W3000387463 cites W1987185969 @default.
• W3000387463 cites W2012867962 @default.
• W3000387463 cites W2013765163 @default.
• W3000387463 cites W2016091072 @default.
• W3000387463 cites W2016971119 @default.
• W3000387463 cites W2019173364 @default.
• W3000387463 cites W2020730385 @default.
• W3000387463 cites W2020810415 @default.
• W3000387463 cites W2021385884 @default.
• W3000387463 cites W2027216206 @default.
• W3000387463 cites W2054874597 @default.
• W3000387463 cites W2059898245 @default.
• W3000387463 cites W2060459188 @default.
• W3000387463 cites W2079551699 @default.
• W3000387463 cites W2087106449 @default.
• W3000387463 cites W2099540110 @default.
• W3000387463 cites W2112539653 @default.
• W3000387463 cites W2120880488 @default.
• W3000387463 cites W2123611122 @default.
• W3000387463 cites W2130648675 @default.
• W3000387463 cites W2130994318 @default.
• W3000387463 cites W2131060408 @default.
• W3000387463 cites W2132897834 @default.
• W3000387463 cites W2135344729 @default.
• W3000387463 cites W2148557257 @default.
• W3000387463 cites W2156921701 @default.
• W3000387463 cites W2165921162 @default.
• W3000387463 cites W2173189766 @default.
• W3000387463 cites W2200269321 @default.
• W3000387463 cites W2255674500 @default.
• W3000387463 cites W2289119904 @default.
• W3000387463 cites W2333220160 @default.
• W3000387463 cites W2402558378 @default.
• W3000387463 cites W2597618526 @default.
• W3000387463 cites W2743950164 @default.
• W3000387463 cites W2889646458 @default.
• W3000387463 cites W2955556244 @default.
• W3000387463 cites W899348315 @default.
• W3000387463 doi "https://doi.org/10.1016/j.ejpb.2019.12.015" @default.
• W3000387463 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31917332" @default.
• W3000387463 hasPublicationYear "2020" @default.
• W3000387463 type Work @default.
• W3000387463 sameAs 3000387463 @default.
• W3000387463 citedByCount "25" @default.
• W3000387463 countsByYear W30003874632020 @default.
• W3000387463 countsByYear W30003874632021 @default.
• W3000387463 countsByYear W30003874632022 @default.
• W3000387463 countsByYear W30003874632023 @default.
• W3000387463 crossrefType "journal-article" @default.
• W3000387463 hasAuthorship W3000387463A5002498340 @default.
• W3000387463 hasAuthorship W3000387463A5007296827 @default.
• W3000387463 hasAuthorship W3000387463A5023893071 @default.
• W3000387463 hasAuthorship W3000387463A5030780763 @default.
• W3000387463 hasAuthorship W3000387463A5035567894 @default.
• W3000387463 hasAuthorship W3000387463A5047430062 @default.
• W3000387463 hasAuthorship W3000387463A5052741873 @default.
• W3000387463 hasAuthorship W3000387463A5056724479 @default.
• W3000387463 hasAuthorship W3000387463A5063502488 @default.
• W3000387463 hasAuthorship W3000387463A5090795535 @default.
• W3000387463 hasAuthorship W3000387463A5091897932 @default.
• W3000387463 hasConcept C121608353 @default.
• W3000387463 hasConcept C126322002 @default.
• W3000387463 hasConcept C150903083 @default.
• W3000387463 hasConcept C178790620 @default.
• W3000387463 hasConcept C185592680 @default.
• W3000387463 hasConcept C190283241 @default.
• W3000387463 hasConcept C203014093 @default.
• W3000387463 hasConcept C207001950 @default.
• W3000387463 hasConcept C2779761222 @default.
• W3000387463 hasConcept C2779820397 @default.

• next